Duloxetine Compared With Placebo in the Prevention of Relapse in Generalized Anxiety Disorder
Clinical trial NCT00122863 · COMPLETED
Trial details
- NCT number
- NCT00122863
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-01-01
- Enrollment
- 380
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.